Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch ...

The Senate health committee announced Thursday morning that it was canceling a planned hearing on Weldon’s nomination because ...

ITF, IntraBio and Orchard are among the companies that have won FDA nods in the past year for Duchenne muscular dystrophy, ...

“We are here to put a face on how important NIH funding is,” said Dianne Larson, Emma’s mother. “We understand that some spending has to give somewhere. But when you have a result, especially ...

Alcausin, director of the National Institutes of Health’s (NIH) Institute of Human Genetics ... medications used to treat rare diseases are known as “orphan drugs” — a term derived from their neglect ...

On March 20 th the Company will be presenting a poster prepared in cooperation with a leading CRO ... costs and reducing time to market for biopharma’s new generations of drugs and therapies.” Green ...

Our science journalists reported on the Stand Up for Science rallies held in New York City and Raleigh, North Carolina.

Q2 2025 Earnings Conference Call February 26, 2025 5:00 PM ETCompany ParticipantsSilviu Itescu - Chief Executive ...

Abrupt cuts by the Trump administration to the US National Institutes of Health threaten progress in medical research ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Freeze on communications and contracts blocks NIH from sharing research materials with collaborators and patenting ...

At NIH, we are working to optimize our resources to support the best science. By centralizing the peer review process, we will not only reduce costs—we will also improve the quality, consistency ...